Literature DB >> 17553848

Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status.

Elmira Anderzhanova1, Mihai Covasa, Andras Hajnal.   

Abstract

The Otsuka Long-Evans Tokushima Fatty (OLETF) rat lacking the CCK-1 receptor is hyperphagic, prefers palatable and high-calorie meals, and gradually develops obesity and type 2 diabetes. To determine dopamine levels in this strain, we used in vivo quantitative (no net flux) microdialysis at three different ages representing nondiabetic (8 wk), prediabetic (18 wk), and diabetic (56 wk) stages in OLETF and age-matched lean Long-Evans Tokushima Otsuka (LETO) controls. Results showed significantly elevated basal dopamine levels in the caudomedial nucleus accumbens of OLETF rats compared with LETO at younger ages (8 wk: 20.10 +/- 5.61 nM vs. 15.85 +/- 5.63 nM; 18 wk: 7.37 +/- 3.71 nM vs. 4.75 +/- 1.25 nM, means +/- SD). In contrast, at 56 wk of age, a profound decline in extracellular dopamine concentrations was seen in both strains with a tendency for a greater effect in OLETF rats (1.78 +/- 0.40 nM vs. 2.39 +/- 0.42 nM). Further, extracellular fraction, an index for reuptake, was higher in 56-wk-old OLETF compared with LETO (0.648 +/- 0.049 vs. 0.526 +/- 0.057). Potassium-stimulated dopamine efflux revealed an increased capacity of vesicular pool in OLETF rats compared with LETO across all age groups with an accentuated strain difference at 56 wk. These findings demonstrate altered striatal dopamine functions (i.e., increased stimulated release and uptake) in obese OLETF rat. This could be due to the lack of functional CCK-1 receptors, or metabolic and hormonal factors associated with the development of obesity and insulin resistance, or both.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553848      PMCID: PMC3114425          DOI: 10.1152/ajpregu.00301.2007

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  76 in total

1.  Overflow of dopamine and cholecystokinin in rat nucleus accumbens in response to acute drug administration.

Authors:  M E Hamilton; J L Redondo; A S Freeman
Journal:  Synapse       Date:  2000-12-01       Impact factor: 2.562

Review 2.  Environmental influences on eating and physical activity.

Authors:  S A French; M Story; R W Jeffery
Journal:  Annu Rev Public Health       Date:  2001       Impact factor: 21.981

3.  Dopamine is required for hyperphagia in Lep(ob/ob) mice.

Authors:  M S Szczypka; M A Rainey; R D Palmiter
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

Review 4.  The ontogeny of postingestive inhibitory stimuli: examining the role of CCK.

Authors:  Aron Weller
Journal:  Dev Psychobiol       Date:  2006-07       Impact factor: 3.038

Review 5.  Hypothalamic dopamine and serotonin in the regulation of food intake.

Authors:  M M Meguid; S O Fetissov; M Varma; T Sato; L Zhang; A Laviano; F Rossi-Fanelli
Journal:  Nutrition       Date:  2000-10       Impact factor: 4.008

Review 6.  Cholecystokinin and satiety: current perspectives.

Authors:  T H Moran
Journal:  Nutrition       Date:  2000-10       Impact factor: 4.008

7.  Nomifensine reveals age-related changes in K(+)-evoked striatal DA overflow in F344 rats.

Authors:  J A Stanford; T D Currier; M S Purdom; G A Gerhardt
Journal:  Neurobiol Aging       Date:  2001 May-Jun       Impact factor: 4.673

8.  Dopamine transporter and D2 receptor binding densities in mice prone or resistant to chronic high fat diet-induced obesity.

Authors:  Xu-Feng Huang; Katerina Zavitsanou; Xin Huang; Yinghua Yu; HongQin Wang; Feng Chen; Andrew J Lawrence; Chao Deng
Journal:  Behav Brain Res       Date:  2006-09-26       Impact factor: 3.332

9.  Dopamine levels modulate the updating of tastant values.

Authors:  R M Costa; R Gutierrez; I E de Araujo; M R P Coelho; A D Kloth; R R Gainetdinov; M G Caron; M A L Nicolelis; S A Simon
Journal:  Genes Brain Behav       Date:  2006-07-17       Impact factor: 3.449

10.  Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens.

Authors:  Vladimir I Chefer; Agustin Zapata; Toni S Shippenberg; Peter M Bungay
Journal:  J Neurosci Methods       Date:  2006-02-08       Impact factor: 2.390

View more
  11 in total

1.  Altered orosensory sensitivity to oils in CCK-1 receptor deficient rats.

Authors:  T D Swartz; A Hajnal; M Covasa
Journal:  Physiol Behav       Date:  2010-01-12

2.  Cocaine- and amphetamine-regulated transcript (CART) peptide immunoreactivity in feeding- and reward-related brain areas of young OLETF rats.

Authors:  Simon Armbruszt; Hajnalka Abraham; Maria Figler; Tamas Kozicz; Andras Hajnal
Journal:  J Chem Neuroanat       Date:  2013-03-29       Impact factor: 3.052

3.  Attenuation of obesity by early-life food restriction in genetically hyperphagic male OLETF rats: peripheral mechanisms.

Authors:  Mariana Schroeder; Timothy H Moran; Aron Weller
Journal:  Horm Behav       Date:  2010-02-13       Impact factor: 3.587

4.  Associations between dopamine D2 receptor availability and BMI depend on age.

Authors:  Linh C Dang; Gregory R Samanez-Larkin; Jaime J Castrellon; Scott F Perkins; Ronald L Cowan; David H Zald
Journal:  Neuroimage       Date:  2016-05-18       Impact factor: 6.556

5.  Cocaine- and amphetamine-regulated transcript peptide immunoreactivity in the brain of the CCK-1 receptor deficient obese OLETF rat.

Authors:  Hajnalka Abraham; Mihai Covasa; Andras Hajnal
Journal:  Exp Brain Res       Date:  2009-06-17       Impact factor: 1.972

Review 6.  Parabrachial coding of sapid sucrose: relevance to reward and obesity.

Authors:  Andras Hajnal; Ralph Norgren; Peter Kovacs
Journal:  Ann N Y Acad Sci       Date:  2009-07       Impact factor: 5.691

7.  Putting desire on a budget: dopamine and energy expenditure, reconciling reward and resources.

Authors:  Jeff A Beeler; Cristianne R M Frazier; Xiaoxi Zhuang
Journal:  Front Integr Neurosci       Date:  2012-07-20

8.  Dopamine Adaptations as a Common Pathway for Neurocognitive Impairment in Diabetes and Obesity: A Neuropsychological Perspective.

Authors:  Dana M Small
Journal:  Front Neurosci       Date:  2017-03-28       Impact factor: 4.677

9.  Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies.

Authors:  Fabio Panariello; Vincenzo De Luca; Andrea de Bartolomeis
Journal:  Schizophr Res Treatment       Date:  2010-12-06

Review 10.  Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease.

Authors:  Artemis P Simopoulos
Journal:  Nutrients       Date:  2013-07-26       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.